IRIS Accounts Production v25.4.12.37 16081217 director 14.11.24 30.11.25 30.11.25 0 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 16081217 2024-11-13 16081217 2025-11-30 16081217 2024-11-14 2025-11-30 16081217 2024-11-13 16081217 ns15:EnglandWales 2024-11-14 2025-11-30 16081217 ns14:PoundSterling 2024-11-14 2025-11-30 16081217 ns10:Director1 2024-11-14 2025-11-30 16081217 ns10:PrivateLimitedCompanyLtd 2024-11-14 2025-11-30 16081217 ns10:SmallEntities 2024-11-14 2025-11-30 16081217 ns10:AuditExemptWithAccountantsReport 2024-11-14 2025-11-30 16081217 ns10:SmallCompaniesRegimeForDirectorsReport 2024-11-14 2025-11-30 16081217 ns10:SmallCompaniesRegimeForAccounts 2024-11-14 2025-11-30 16081217 ns10:FullAccounts 2024-11-14 2025-11-30 16081217 ns10:RegisteredOffice 2024-11-14 2025-11-30 16081217 ns5:CurrentFinancialInstruments 2025-11-30 16081217 ns5:ShareCapital 2025-11-30 16081217 ns5:RetainedEarningsAccumulatedLosses 2025-11-30 16081217 ns5:CurrentFinancialInstruments 2024-11-14 2025-11-30 16081217 ns10:Director1 1 2024-11-13 16081217 ns10:Director1 1 2024-11-14 2025-11-30 16081217 ns10:Director1 1 2025-11-30

REGISTERED NUMBER: 16081217 (England and Wales)

SALIX BABYLONICA MEDICAL SERVICES

LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD

14 NOVEMBER 2024 TO 30 NOVEMBER 2025

| SALIX BABYLONICA MEDICAL SERVICES |

| LIMITED (REGISTERED NUMBER: 16081217) |

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE PERIOD 14 NOVEMBER 2024 TO 30 NOVEMBER 2025

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 3 |

| Chartered Accountants' Report | 5 |

| SALIX BABYLONICA MEDICAL SERVICES |

| LIMITED |

COMPANY INFORMATION

FOR THE PERIOD 14 NOVEMBER 2024 TO 30 NOVEMBER 2025

| DIRECTOR: | Dr S Cahill

| REGISTERED OFFICE: | 8 Cae Ffynnon

| Cowbridge

| CF71 7FJ

| REGISTERED NUMBER: | 16081217 (England and Wales)

| ACCOUNTANTS: | Bevan Buckland LLP

| Ground Floor Cardigan House

| Castle Court

| Swansea Enterprise Park

| Swansea

| SA7 9LA

| SALIX BABYLONICA MEDICAL SERVICES |

| LIMITED (REGISTERED NUMBER: 16081217) |

BALANCE SHEET

30 NOVEMBER 2025

| Notes | £ |

| CURRENT ASSETS

| Cash at bank | 10,975 |  |

| CREDITORS

| Amounts falling due within one year | 4 | 8,799 |  |

| NET CURRENT ASSETS | 2,176 |  |

| TOTAL ASSETS LESS CURRENT LIABILITIES | 2,176 |  |

| CAPITAL AND RESERVES

| Called up share capital | 1 |  |

| Retained earnings | 2,175 |  |

2,176 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 17 March 2026 and were signed by:

Dr S Cahill - Director

| SALIX BABYLONICA MEDICAL SERVICES |

| LIMITED (REGISTERED NUMBER: 16081217) |

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD 14 NOVEMBER 2024 TO 30 NOVEMBER 2025

1. | STATUTORY INFORMATION

| Salix Babylonica Medical Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover comprises income from private GP services. Income is recognised on an accruals basis.

| Taxation

| Taxation for the period comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Cash at bank and cash in hand

| Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

| Financial instruments

| The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12

| 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments .Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

| Creditors

| Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

| Debtors

| Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured

| initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the

| effective interest method, less any impairment.

| SALIX BABYLONICA MEDICAL SERVICES |

| LIMITED (REGISTERED NUMBER: 16081217) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE PERIOD 14 NOVEMBER 2024 TO 30 NOVEMBER 2025

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the period was NIL.

4. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

£ |

| Taxation and social security | 3,208 |  |

| Other creditors | 5,591 |  |

8,799 |  |

| Included in creditors is an amount of £4,451 which is monies owed to the director. This amount is interest free and repayable upon demand.

5. | DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

| The following advances and credits to a director subsisted during the period ended 30 November 2025:

£ |

| Dr S Cahill |

| Balance outstanding at start of period | - |  |

| Amounts advanced | 17,211 |  |

| Amounts repaid | (21,662 | ) |

| Amounts written off | - |  |

| Amounts waived | - |  |

| Balance outstanding at end of period | (4,451 | ) |

CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR

ON THE UNAUDITED FINANCIAL STATEMENTS OF

SALIX BABYLONICA MEDICAL SERVICES

LIMITED

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Salix Babylonica Medical Services Limited for the period ended 30 November 2025 which comprise the Statement of Income and Retained Earnings, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Salix Babylonica Medical Services Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Salix Babylonica Medical Services Limited and state those matters that we have agreed to state to the director of Salix Babylonica Medical Services Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Salix Babylonica Medical Services Limited and its director for our work or for this report.

It is your duty to ensure that Salix Babylonica Medical Services Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Salix Babylonica Medical Services Limited. You consider that Salix Babylonica Medical Services Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of Salix Babylonica Medical Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Bevan Buckland LLP

Ground Floor Cardigan House

Castle Court

Swansea Enterprise Park

Swansea

SA7 9LA

17 March 2026